CRISPR Therapeutics (CRSP) PT Raised to $90 at Credit Suisse

August 8, 2022 4:18 PM EDT Send to a Friend

Credit Suisse analyst Richard Law ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CRISPR Therapeutics (CRSP) PT Raised to $90 at Credit Suisse

Member Login

Free News Feed